PRIMARY STUDY

Therapeutic potential of minor cannabinoids in psychiatric disorders: A systematic review

Key Findings:  This systematic review highlights the potential of minor cannabinoids, such as Δ8-THCV, Δ9-THCV, CBDA-ME, and CBDV, for treating psychiatric disorders like addiction, psychosis, anxiety, depression, and autism, while emphasizing the need for further research due to limited and heterogeneous evidence.